Cullin 2 antibody (AA 389-745)
Quick Overview for Cullin 2 antibody (AA 389-745) (ABIN7982009)
Target
See all Cullin 2 (CUL2) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Grade
-
-
Binding Specificity
- AA 389-745
-
Purpose
- Anti-CUL2 Antibody
-
Specificity
- No cross reactivity with other proteins.
-
Cross-Reactivity (Details)
- No cross-reactivity with other proteins.
-
Characteristics
- Anti-CUL2 Antibody. Tested in ELISA, Flow Cytometry, WB applications. This antibody reacts with Human, Mouse, Rat.
-
Purification
- Immunogen affinity purified.
-
Immunogen
- E. coli-derived human CUL2 recombinant protein (Position: E389-A745).
-
Isotype
- IgG
-
-
-
-
Application Notes
- Western blot, 0.1-0.5 μg/mL Flow Cytometry(Fixed), 1-3 μg/1x106 cells ELISA, 0.1-0.5 μg/mL
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
-
Concentration
- 500 μg/mL
-
Buffer
- Each vial contains 4 mg Trehalose, 0.9 mg NaCl and 0.2 mg Na2HPO4.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Store at -20°C for one year from date of receipt. After reconstitution, at 4°C for one month.
It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freeze-thaw cycles. -
Expiry Date
- 12 months
-
-
- Cullin 2 (CUL2)
-
Alternative Name
- CUL2
-
Background
-
Background: Cullin 2 (CUL2) is a protein that in humans is encoded by the CUL2 gene. Using immunofluorescence, it is showed that CUL2 is a cytosolic protein that can be translocated to the nucleus by VHL. By fluorescence in situ hybridization, this gene is mapped to 10p11.2-p11.1, a region reported to show loss of heterozygosity (LOH) in several forms of human cancer, including non-clear cell renal cell carcinoma. CUL2 may serve as a rigid scaffold in the complex and may contribute to catalysis through positioning of the substrate and the ubiquitin-conjugating enzyme.
Gene Full Name: cullin 2
-
Molecular Weight
- 87 kDa
-
Gene ID
- 8453
-
UniProt
- Q13617
-
Pathways
- M Phase, Asymmetric Protein Localization, SARS-CoV-2 Protein Interactome
Target
-